NATIONAL GUARD HEALTH AFFAIRS
🇸🇦Saudi Arabia
- Country
- 🇸🇦Saudi Arabia
- Ownership
- -
- Established
- 1983-01-01
- Employees
- -
- Market Cap
- -
Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients
Phase 3
Suspended
- Conditions
- Interventions
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 150
- Registration Number
- NCT01356329
- Locations
- 🇸🇦
King Abdul Aziz Medical City for National Guard Health Affairs, Riyadh, Saudi Arabia
Breast Cancer in Young Women: Is it Different?
Suspended
- Conditions
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 600
- Registration Number
- NCT01320488
- Locations
- 🇸🇦
King Abdul Aziz Medical City for National Guard Health Affairs, Riyadh, Saudi Arabia
Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 100
- Registration Number
- NCT01320501
- Locations
- 🇸🇦
King Abdul Aziz Medical City for National Guard Health Affairs, Riyadh, Saudi Arabia
Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer
Phase 2
Terminated
- Conditions
- First Posted Date
- 2008-03-17
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 9
- Registration Number
- NCT00636883
- Locations
- 🇸🇦
National Guard Health Affairs, Riyadh, Saudi Arabia
© Copyright 2024. All Rights Reserved by MedPath